HomeVVY • AMS
add
Vivoryon Therapeutics NV
Previous close
€2.04
Day range
€1.94 - €2.06
Year range
€0.41 - €9.93
Market cap
53.47M EUR
Avg Volume
116.18K
P/E ratio
-
Dividend yield
-
Primary exchange
AMS
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.90M | 29.15% |
Net income | -6.78M | -26.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -6.88M | -29.12% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.27M | -60.42% |
Total assets | 16.99M | -62.54% |
Total liabilities | 3.01M | -21.20% |
Total equity | 13.98M | — |
Shares outstanding | 26.07M | — |
Price to book | 3.77 | — |
Return on assets | -101.59% | — |
Return on capital | -123.38% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -6.78M | -26.53% |
Cash from operations | -6.65M | 34.43% |
Cash from investing | 5.00M | 111,211.11% |
Cash from financing | -14.00K | -100.12% |
Net change in cash | -1.64M | -208.69% |
Free cash flow | -3.68M | -70.07% |
About
Founded
1997
Website
Employees
15
